BALDWIN PARK, Calif. , Nov. 5, 2025 /PRNewswire/ -- StemCyte International (TPEX: 4178) , a global leader in cord blood banking and cell therapy, today announced the launch of its Public Bank Matching Protection Service in Taiwan, developed in collaboration with leading insurance partner, Taishin Life. This first-of-its-kind model connects insurance coverage to public cord blood resources, transforming how families access transplant protection while reinforcing the unmatched scale of StemCyte's dual public-private bank. StemCyte is the only cell therapy company in Taiwan to collaborate with the insurance industry to offer this type of service, establishing a new benchmark that connects life insurance coverage with access to cell therapy.

"We are the first to integrate this innovative

See Full Page